Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Central nervous system activity, Effective for EGFR Ex19Del or L858R mutations,
Sale!
Lucius
Replica Osimertinib EGFR m NSCLC Targeted Therapy
Original price was: $668.00.$509.00Current price is: $509.00.
Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Central nervous system activity, Effective for EGFR Ex19Del or L858R mutations,
Reviews
There are no reviews yet.